Sharps Technology, Inc. (STSS)
NASDAQ: STSS · IEX Real-Time Price · USD
0.289
-0.006 (-2.00%)
At close: Apr 24, 2024, 4:00 PM
0.286
-0.003 (-0.93%)
After-hours: Apr 24, 2024, 4:41 PM EDT
Company Description
Sharps Technology, Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States.
It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications.
Sharps Technology, Inc. was incorporated in 2017 and is based in Melville, New York.
Sharps Technology, Inc.
| Country | United States |
| Founded | 2017 |
| IPO Date | Apr 14, 2022 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 57 |
| CEO | Robert M. Hayes |
Contact Details
Address: 105 Maxess Road, Ste. 124 Melville, New York 11747 United States | |
| Phone | (631) 574 -4436 |
| Website | sharpstechnology.com |
Stock Details
| Ticker Symbol | STSS |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $4.25 |
| CIK Code | 0001737995 |
| CUSIP Number | 82003F101 |
| ISIN Number | US82003F1012 |
| Employer ID | 82-3751728 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Robert M. Hayes | Chief Executive Officer and Director |
| Andrew R. Crescenzo CPA | Chief Financial Officer |
| Ben Scheu | Senior Director of Sales |
| Dr. Steven Hertz M.D. | Chief Medical Officer |
| Adam S. Holdsworth | Managing Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 29, 2024 | 10-K | Annual Report |
| Mar 8, 2024 | 8-K | Current Report |
| Mar 7, 2024 | 8-K | Current Report |
| Feb 14, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Jan 19, 2024 | 8-K | Current Report |
| Jan 18, 2024 | 8-K | Current Report |
| Jan 9, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Dec 22, 2023 | 8-K | Current Report |
| Dec 20, 2023 | 8-K | Current Report |
| Nov 14, 2023 | 10-Q | Quarterly Report |